Registration is now open for our 16th National Conference which will be held in-person in San Francisco, CA from October 28th-30th, 2021, as well as broadcast virtually.
We are thrilled to invite you to this event, which features over 30 nationally recognized anticoagulation experts, who will each be presenting live, in-person!
In order to best support members who may have on-going travel restrictions, we are pleased to offer a virtual attendance option. Sessions will be live streamed with the opportunity to submit questions to presenters in real-time.
Visit our Registration Page to learn more about the Conference experience and whether in-person or virtual attendance is right for you.
Early Registration ends July 1st!
AC Forum Turns 30!
We are so excited to celebrate our 30 years of education and impact and to welcome our new president, Dr. Allison Burnett!!>
Watch the video below to hear AC Forum leaders share their stories, experiences, and future goals for our organization!
30th ANNIVERSARY HIGHLIGHT VIDEO
Managing Anticoagulation During the COVID-19 Pandemic
AC Forum will continue to offer guidance on how best to protect your patients and staff while providing anticoagulation management during the current pandemic. Check back often for new updates!
In recognizing the impact of systemic racism on health disparities, the Anticoagulation Forum has established the Inclusion, Diversity, Equity, and Allyship (IDEA) Committee. Through the IDEA Committee, the AC Forum will work to increase awareness and promote diversity in our leadership, membership, and programming. We hope our members will engage in this initiative to re-evaluate their current practice, reduce health inequities, and improve the quality of care for all patients.
Learn more here.
News & Announcements:
DOACs and Obesity in 2021: Updates from the ISTH SSC Subcommittee on Control of Anticoagulation
Don’t miss our upcoming webinar on Wednesday, September 15, 2021 @ 12:00 PM ET
In 2016, the SSC of the ISTH published recommendations and guidance discouraging routine use of DOACs in patients weighing more than 120kg or with a BMI exceeding 40 kg/m2. Since that time, multiple bodies of work have been published addressing this issue. Recently, the SSC of the ISTH published updated recommendations addressing the use of DOACs to treat VTE in obese patients as well as those who have undergone bariatric surgery. This webinar will address the topic of DOACs in the obese, with a focus on the updated guidance.
Speaker & 1st Author:
• Karlyn Martin, MD
• Stephan Moll, MD
• Arthur Allen, PharmD, CACP
• Deborah Siegal, MD, MSc
• Andrea Van Beek, RN DNP AGPCNP-BC
Link to guidance:
Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation: https://pubmed.ncbi.nlm.nih.gov/34259389
We are pleased to provide enduring accreditation for this webinar!
Practitioner's Guide for Improving Oral Anticoagulant Use, Online CE from the FDA (CE), June 2020
Free 1-hour course from the FDA on all the fundamental aspects of oral anticoagulation management including overviews of disease state & risk assessment, warfarin, DOACs, DDIs and patient issues such as compliance & joint decision-making; slides and transcript available for download; 1 hour of continuing education credit is available for physicians, nurses & pharmacists until 6/1/23.
View Course Here
FDA-funded Anticoagulation Stewardship Guide
Download our new FDA-funded release, Core
Elements of the Anticoagulation Stewardship Program, which outlines systemic protocols
designed to improve the safety and quality of care for patients and reduce the adverse drug effects related
to anticoagulant medications.